Ardent Health, Inc.(ARDT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #834 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ARDT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Ardent Health, Inc. (ARDT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ARDT at 60.7/100 on a 32-signal composite quality model, placing it at rank #834 of 2,879 stocks — the top half of the AI-ranked universe. ARDT scores in the top quartile across earnings quality (87.7), revenue scale (81.6). Areas of concern include institutional flow (34.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Ardent Health, Inc. reports quarterly revenue of $1.6B, net income of $39.9M, an operating margin of 4.7%. Top institutional holders of ARDT by reported 13-F value include CHAI CO, Ventas,, GOLDENTREE ASSET MANAGEMENT, based on the most recent SEC filings. ARDT trades on the NYSE exchange and files with the SEC under CIK 1756655. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARDT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ardent Health, Inc. directly from SEC EDGAR. Ardent Health, Inc.'s 13F Pro composite quality score has ranged between 8 and 64 since 2025, currently 60.7 — an improving long-term trajectory across 40 quarterly and live scoring snapshots.
Revenue
Q1 2026
$1.6B
Net Income
Q1 2026
$39.9M
Free Cash Flow
Q1 2026
$-60.2M
Operating Margin
Q1 2026
4.7%
ROIC
Q1 2026
3.1%
D/E Ratio
Q1 2026
0.86
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+6.0% YoYNet Income
-35.4% YoYEPS (Diluted)
-39.2% YoYTotal Assets
+6.7% YoYTotal Debt
+2.7% YoYOp. Cash Flow
+49.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $6.32B +6.0% | $5.97B +10.3% | $5.41B +5.5% | $5.13B | — |
| Net Income | $135.8M -35.4% | $210.3M +290.2% | $53.9M -71.5% | $188.9M | — |
| EPS (Diluted) | $0.96 -39.2% | $1.58 +267.4% | $0.43 -71.3% | $1.50 | — |
| Total Assets | $5.29B +6.7% | $4.96B +4.7% | $4.73B | — | — |
| Total Debt | $1.16B +2.7% | $1.13B -6.0% | $1.21B | — | — |
| Operating Cash Flow | $470.5M +49.4% | $315.0M +42.1% | $221.7M +678.0% | $-38.4M | — |
Get alerted when ARDT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Ardent Health, Inc. including:
Top Institutional Holders of ARDT
CHAI TRUST CO LLC
$661.2M77,246,499 shVentas, Inc.
$80.0M9,342,501 shGOLDENTREE ASSET MANAGEMENT LP
$19.7M2,303,113 shAMERIPRISE FINANCIAL INC
$15.2M1,776,726 shBlackRock, Inc.
$15.1M1,758,215 shCastleKnight Management LP
$9.2M1,076,967 shVANGUARD CAPITAL MANAGEMENT LLC
$8.6M1,008,438 shAQR CAPITAL MANAGEMENT LLC
$8.1M942,353 shBRIDGEWAY CAPITAL MANAGEMENT, LLC
$8.0M930,668 shExodusPoint Capital Management, LP
$5.6M657,903 sh
| Fund | Value | Shares |
|---|---|---|
| CHAI TRUST CO LLC | $661.2M | 77,246,499 |
| Ventas, Inc. | $80.0M | 9,342,501 |
| GOLDENTREE ASSET MANAGEMENT LP | $19.7M | 2,303,113 |
| AMERIPRISE FINANCIAL INC | $15.2M | 1,776,726 |
| BlackRock, Inc. | $15.1M | 1,758,215 |
| CastleKnight Management LP | $9.2M | 1,076,967 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.6M | 1,008,438 |
| AQR CAPITAL MANAGEMENT LLC | $8.1M | 942,353 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $8.0M | 930,668 |
| ExodusPoint Capital Management, LP | $5.6M | 657,903 |
More Healthcare Companies
View all Healthcare →Put ARDT on your watchlist
Track score changes the day Ardent Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ARDT a good stock to buy?
13F Pro's AI-powered analysis of Ardent Health, Inc. (ARDT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ARDT are available on the ARDT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ARDT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ARDT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Ardent Health, Inc.'s investment landscape.